Peters U, McGlynn K A, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA.
Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1267-74.
Experimental studies suggest that vitamin D and calcium protect against cancer by reducing proliferation and inducing differentiation. The effects of vitamin D and calcium may be mediated by the vitamin D receptor (VDR), which is encoded by the VDR gene. The present study investigated whether calcium intake and serum vitamin D, as an integrated measure of intake and endogenous production, were associated with risk of colorectal adenoma, known precursors of invasive colorectal cancer. In addition, the interrelation among vitamin D, calcium, and FokI polymorphism of the VDR gene was investigated. Persons (239) with histologically confirmed colorectal adenomas and 228 control individuals without colorectal adenomas confirmed by sigmoidoscopy were enrolled in this case control study conducted at the National Naval Medical Center, Bethesda, MD. We observed an inverse association of serum 25-OH vitamin D [25-(OH)D] with colorectal adenoma. With each 10 ng/ml increase of serum 25-(OH)D, the risk of colorectal adenoma decreased by 26% (odds ratio 0.74, 95% confidence interval 0.60-0.92). The results provided limited evidence for a weak association between calcium intake and colorectal adenoma (odds ratio 0.97, 95% confidence interval 0.93-1.01 per each 100-mg calcium intake). However, the inverse association of serum 25-(OH)D with colorectal adenoma is suggested to be stronger in subjects with calcium intake above the median (P for multiplicative interaction 0.13). The VDR FokI polymorphism was not significantly associated with colorectal adenoma and did not modify the effect of vitamin D or calcium. In conclusion, the study results suggested a protective effect for vitamin D on colorectal adenoma.
实验研究表明,维生素D和钙可通过减少细胞增殖和诱导分化来预防癌症。维生素D和钙的作用可能由维生素D受体(VDR)介导,VDR由VDR基因编码。本研究调查了作为摄入和内源性产生综合指标的钙摄入量和血清维生素D是否与结直肠腺瘤(侵袭性结直肠癌的已知前体)风险相关。此外,还研究了维生素D、钙与VDR基因FokI多态性之间的相互关系。本病例对照研究在马里兰州贝塞斯达的国家海军医疗中心进行,纳入了239例经组织学确诊的结直肠腺瘤患者和228例经乙状结肠镜检查证实无结直肠腺瘤的对照个体。我们观察到血清25-羟基维生素D [25-(OH)D]与结直肠腺瘤呈负相关。血清25-(OH)D每增加10 ng/ml,结直肠腺瘤风险降低26%(比值比0.74,95%置信区间0.60 - 0.92)。结果为钙摄入量与结直肠腺瘤之间的弱关联提供了有限证据(每摄入100毫克钙,比值比0.97,95%置信区间0.93 - 1.01)。然而,在钙摄入量高于中位数的受试者中,血清25-(OH)D与结直肠腺瘤的负相关似乎更强(相乘交互作用P值为0.13)。VDR FokI多态性与结直肠腺瘤无显著关联,也未改变维生素D或钙的作用。总之,研究结果表明维生素D对结直肠腺瘤有保护作用。